Logo image
Apolipoprotein E ϵ4 in inclusion body myositis
Journal article   Peer reviewed

Apolipoprotein E ϵ4 in inclusion body myositis

M.J. Garlepp, H. Tabarias, F.M. van Bockxmeer, P.J. Zilko, B. Laing and F.L. Mastaglia
Annals of Neurolog, Vol.38(6), pp.957-959
1995
url
Link to Published Version *Subscription may be requiredView

Abstract

The genetic predisposition to inclusion body myositis (IBM) is probably multifactorial. The deposition of the β-amyloid protein is a characteristic histological feature of both IBM and Alzheimer's disease (AD). The ϵ4 allele of apolipoprotein E (APO E) has been strongly associated with familial and late-onset AD. We therefore compared the APO E allele frequencies in a group of 14 patients with IBM with those in a group of patients with other inflammatory muscle diseases and in the general population. The frequency of the ϵ4 allele in IBM was increased (0.29) compared with that in patients with other inflammatory muscle diseases (0.15) and the general population (0.13) (p < 0.05). These data suggest that APO E genotype may be one of the factors involved in determining the predisposition to the development of IBM.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.52 Neurodegenerative Diseases
1.52.57 Alzheimer's Mechanisms
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image